Saturday 17 October 2026
Export AFMDQ’s income statement to Excel — free account
Affimed N.V.
AFMDQ Healthcare Biotechnology
Affimed N.V.’s revenue for fiscal 2023 (year ended December 2023) was $9.0 million, down 79.4% from fiscal 2022.
0.00
0.00
NaN
Follow AFMDQ
| Dec '18 | Jan '19 | Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | — | 3 | — | 3 | — | 2 | — | 2 | 1 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(1.90) | — | (2.80) | — | (1.87) | — | (1.70) | — | (1.17) | (10.41) |
P/S ratio |
0.67 | 0.70 | 0.73 | 0.71 | 1.50 | 1.56 | 1.38 | 14.14 | 0.40 | 10.43 |
Altman Z″-Score (non-manufacturers) |
(2.07) | — | (4.06) | — | (2.59) | — | (1.01) | — | (1.29) | (19.89) |
P/FCF ratio |
0.33 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
12.68 | — | (2.61) | — | (1.61) | — | (1.29) | — | (2.90) | 15.08 |
P/Operating CF |
0.22 | 0.22 | 11.74 | 11.36 | 2.57 | 2.68 | (2.00) | (20.51) | (0.48) | (3.46) |
P/B ratio |
0.40 | 0.41 | 0.41 | 0.39 | 0.59 | 0.62 | 0.41 | 4.20 | 0.11 | 1.49 |
Price to Tangible BV |
0.40 | 0.41 | 0.41 | 0.39 | 0.61 | 0.63 | 0.42 | 4.25 | 0.11 | 1.49 |
EV/Sales |
(3.71) | (3.69) | (4.02) | (4.05) | (3.67) | (3.61) | (3.08) | 9.68 | (3.78) | 3.09 |
EV/EBITDA |
4.60 | 4.57 | 2.73 | 2.75 | 3.10 | 3.04 | 1.98 | 0.00 | 1.83 | 0.00 |
EV/Operating CF |
(1.78) | (1.77) | 2.96 | 2.98 | 5.36 | 5.27 | 1.43 | (4.51) | 1.49 | (0.23) |
EV/FCF |
(1.81) | (1.80) | 2.82 | 2.84 | 5.24 | 5.15 | 1.37 | (4.32) | 1.46 | (0.22) |
Quick Ratio |
2.99 | 3.00 | 3.00 | 2.23 | 2.23 | 3.14 | 3.14 | 5.57 | 5.57 | 3.02 |
Current Ratio |
3.01 | 3.01 | 3.01 | 2.25 | 2.25 | 3.20 | 3.20 | 5.66 | 5.66 | 3.25 |
Net Debt/EBITDA |
5.44 | 3.19 | 3.23 | 4.56 | 4.36 | 2.69 | 2.87 | 2.02 | 2.03 | 0.58 |
Debt/Assets |
4.11% | 2.84% | 2.12% | 0.74% | 0.18% | 8.30% | 7.84% | 9.07% | 8.79% | 12.51% |
Debt/Equity |
0.12 | 0.08 | 0.06 | 0.02 | 0.00 | 0.14 | 0.13 | 0.12 | 0.12 | 0.21 |
Asset Turnover |
0.30 | 0.00 | 0.18 | 0.00 | 0.20 | 0.00 | 0.20 | 0.00 | 0.18 | 0.06 |
Operating CF/Net income |
(2.54) | 0.90 | 0.90 | 0.47 | 0.47 | 1.51 | 1.51 | 1.22 | 1.22 | 1.04 |
Capex/Depreciation |
(1.79) | 0.00 | (1.63) | 0.00 | (0.39) | 0.00 | (2.89) | 0.00 | (0.24) | (2.13) |
| (55.37%) | 0.00% | (79.93%) | 0.00% | (75.28%) | 0.00% | (55.99%) | 0.00% | (56.29%) | (102.52%) | |
| (24.74%) | 0.00% | (27.56%) | 0.00% | (28.94%) | 0.00% | (29.14%) | 0.00% | (37.94%) | (72.47%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(25.81%) | (43.70%) | (44.32%) | (44.33%) | (48.10%) | (40.77%) | (39.49%) | (51.08%) | (52.05%) | (167.66%) |
Average Days of Receivables |
21.97 | 25.36 | 25.29 | 33.69 | 31.39 | 41.84 | 43.48 | 24.17 | 23.81 | 234.97 |
Research and Development Expense of Revenue |
148.09% | 201.33% | 204.72% | 173.32% | 176.27% | 199.25% | 201.87% | 232.57% | 238.95% | 1,147.53% |
Selling, General and Administrative Expense of Revenue |
40.61% | 47.15% | 47.99% | 47.37% | 48.36% | 59.31% | 60.00% | 76.94% | 77.56% | 298.19% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
8.57% | 0.00% | 11.54% | 0.00% | 11.92% | 0.00% | 29.28% | 0.00% | 46.21% | 129.48% |
Graham Net Nets |
2.19 | 2.11 | 2.05 | 2.12 | 1.11 | 1.06 | 2.10 | 0.21 | 9.08 | 0.52 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(125.40%) | (121.12%) | (193.43%) | (200.00%) | (99.66%) | (95.71%) | (102.42%) | (10.01%) | (520.66%) | (122.47%) |
Free Cash Flow Yield |
305.72% | 295.28% | (194.26%) | (200.85%) | (46.65%) | (44.80%) | (162.21%) | (15.85%) | (657.14%) | (134.26%) |
Revenue per Share |
4.63 | 0.37 | 3.73 | 0.39 | 3.88 | 0.40 | 4.00 | 0.31 | 3.06 | 0.60 |
Operating CF per Share |
9.65 | (0.51) | (5.07) | (0.26) | (2.65) | (0.86) | (8.57) | (0.77) | (7.76) | (7.99) |
Capex per Share |
(0.14) | 0.00 | (0.26) | 0.00 | (0.06) | 0.00 | (0.38) | 0.00 | (0.05) | (0.27) |
Free Cash Flow per Share |
9.51 | (0.51) | (5.32) | (0.26) | (2.72) | (0.86) | (8.95) | (0.77) | (7.81) | (8.26) |
Cash per Share |
21.23 | 1.82 | 18.16 | 2.15 | 20.10 | 1.88 | 19.57 | 1.43 | 14.08 | 5.28 |
Shareholders Equity per Share |
7.83 | 0.68 | 6.74 | 1.06 | 9.85 | 1.29 | 13.46 | 1.15 | 11.32 | 4.19 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.83 | 0.68 | 6.74 | 1.06 | 9.85 | 1.29 | 13.46 | 1.15 | 11.32 | 4.19 |
Free Cash Flow |
57.54 | (32.52) | (34.19) | (22.12) | (22.66) | (102.35) | (107.00) | (110.24) | (111.25) | (123.38) |
Working Capital |
87.44 | 79.40 | 79.22 | 102.50 | 95.69 | 161.31 | 167.82 | 172.27 | 170.07 | 63.08 |
Capital Expenditures |
(0.85) | (1.65) | (1.65) | (0.50) | (0.50) | (4.55) | (4.55) | (0.73) | (0.73) | (4.04) |
Net Current Asset Value |
41.14 | 36.17 | 36.09 | 57.59 | 53.76 | 133.29 | 138.67 | 158.46 | 156.43 | 48.53 |
EV/EBIT |
4.51 | 4.48 | 2.66 | 2.67 | 3.00 | 2.95 | 1.94 | 0.00 | 1.77 | 0.00 |
Capex to Sales |
0.03 | 0.00 | 0.07 | 0.00 | 0.02 | 0.00 | 0.10 | 0.00 | 0.02 | 0.45 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.29 | 0.40 | 0.33 | 0.50 | 0.29 | 0.35 | 0.65 | 0.76 | 0.36 |
Cash ROIC |
31.70% | (19.85%) | (21.03%) | (8.21%) | (9.05%) | (25.55%) | (25.75%) | (28.58%) | (29.26%) | (79.80%) |
Accounts Receivable Turnover |
19.11 | 0.00 | 14.31 | 0.00 | 14.57 | 0.00 | 11.27 | 0.00 | 10.21 | 2.08 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.47 | 1.68 | 1.67 | 2.32 | 2.22 | 4.13 | 4.24 | 4.28 | 4.27 | 4.30 |
Average Payables |
7.93 | 11.32 | 11.54 | 10.86 | 12.49 | 16.22 | 17.66 | 20.08 | 21.21 | 20.29 |
Average Inventory |
0.29 | 0.32 | 0.32 | 0.32 | 0.31 | 0.38 | 0.39 | 0.58 | 0.58 | 0.58 |
Average Assets |
92.99 | 131.66 | 131.52 | 170.43 | 163.29 | 228.38 | 233.54 | 240.18 | 238.81 | 158.21 |
Average Common Equity |
41.54 | 45.40 | 45.35 | 65.70 | 62.77 | 118.42 | 121.54 | 162.02 | 160.98 | 111.84 |
Columns are period end dates